Chronic pain affects 100 million Americans. Certain patients with chronic pain are candidates for intrathecal (IT) therapy, which can mitigate some of the risks associated with systemic opioids. Following appropriate patient selection based on medical and psychiatric history and a physical exam, a patient can begin a trial with morphine or ziconotide, the 2 US Food and Drug Administration (FDA)–approved IT therapies. Monitoring for adverse events should continue after IT pump implantation, as should monitoring for catheter- or pump-related complications. This CME-accredited Point of Care 201™ 2-part series discusses identification of candidates for IT therapy, available IT therapies, optimal treatment initiation and management, and both surgical implantation and pump refill techniques.
Find the latest continuing medical courses in the managed care of adult patients. These activities are designed to meet the educational needs of health care professionals who are involved with the care of adult patients.
This is a freely accessible, educational platform for healthcare providers who treat patients with type 1 diabetes. Our goal is to ensure that you – the practicing clinician – have access to the most accurate, up-to-date information including complimentary CE activities and educational resources that you can share with your patients.
We know you will find these resources helpful in your clinical practice, and hope that you will share relevant information with your colleagues and patients.
The Angiogenesis Foundation convened an expert virtual roundtable on optimizing clinical utilization and long-term treatment outcomes in AMD. The panel of experts shared their perspectives on and recommendations for long-term treatment outcomes in age-related macular degeneration. The program materials consist of an audio recording of the virtual roundtable, infographics illustrating the major points of the discussion, and a white paper report.
Symptoms and Underlying Pathology in the Diagnosis and Optimal Management of Atopic Dermatitis (AD): A 5-part Elsevier Learning Center.
Both hyperuricemia and gout are increasingly prevalent in the United States, though there are often deficits surrounding diagnosis, ongoing assessment and management. In two 15-minute discussions, listen as two experts discuss case-based examples of gout, providing clinicians with knowledge and increased competence for managing patients with gout.
Focusing on Patients With Severe Asthma: From Guideline Recommendations to Daily Clinical Decision-MakingFormat: Webcast Series
Welcome to this Severe Asthma CME Snapshot ™ video series. Each 15-minute module offers focused, clinically actionable education for pulmonologists, clinical immunologists, and other clinicians who manage patients with severe asthma. For a comprehensive curriculum that provides a practical set of recommendations to improve daily functioning and quality of life among patients with severe asthma, clinician learners can complete all 4 modules for a full hour of AMA PRA Category 1 Credit ™.
This CME-accredited CME Snapshot™ four-part series is intended for endocrinologists, primary care providers (PCPs), and other health care providers involved in the identification, evaluation, and treatment of patients with T2DM. During these activities, two expert faculty will participate in a series of interactive discussions on recent evidence related to glucagon-like peptide 1 receptor agonists (GLP-1 RAs). The faculty will also review freely available patient- and caregiver directed educational resources that seek to improve shared decision-making.
Best Practices in Intrathecal Therapy for Chronic Pain: Patient Selection, Treatment Initiation, and Ongoing MonitoringFormat: Webcast Series
Welcome to this Chronic Pain CME Snapshot™ video series. Each 15-minute module offers focused, clinically actionable education for pain specialists, nurses and other clinicians who manage patients treated with intrathecally delivered analgesics for chronic pain. For a comprehensive curriculum that provides a practical set of recommendations on improving daily functioning and quality of life among patients with chronic pain, clinician learners can complete all 4 modules for a full hour of AMA PRA Category 1 Credit™.
Breathing Life Into COPD Management: Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized CareFormat: Webcast Series
This CME-accredited CME Snapshot™ educational series, Breathing Life Into COPD Management: Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care is intended for primary care clinicians and other health care providers involved in the ongoing management of patients with chronic obstructive pulmonary disease (COPD). Within each focused activity, an expert pulmonologist and a primary care educator discuss best practices for a specific aspect of managing patients with COPD, including monitoring the disease course over time, maximizing patient function, and individualizing treatment regimens. One activity also addresses patients’ perspectives by incorporating patient-clinician interactions and insights into disease burdens, challenges to good long-term outcomes, and shared decision-making.
Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic progressive fibrotic lung disease of unknown cause. Early diagnosis is a prerequisite for earlier treatment and, potentially, improved long-term clinical outcomes. Familiarity with novel treatment approaches that hold the promise of slowing disease progression and with the recent guideline recommendations is essential for all clinicians involved in the care of patients with IPF. Individualizing treatment is important in light of potential improved adherence to both drug therapy and health behaviors.
Evolving Treatment Paradigms for Rheumatoid Arthritis: Translating Comprehensive Patient Evaluations Into Personalized TherapyFormat: Webcast Series
Welcome to this RA CME Snapshot™ video series. Each 15-minute module offers focused, clinically actionable education for rheumatologists and other clinicians who manage patients with RA. For a comprehensive curriculum on current evidence-based guidelines and newly published data on the use of targeted inhibitors of interleukin (IL)-6 or Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathways, clinicians can complete all 6 video modules for a total of 1.5 AMA PRA Category 1 Credits™ or 1.5 hours of nursing contact hours.
The AAT-AD/PD™ Focus Meeting 2018 was held in Turin, Italy, March 15-18, 2018. During the new joint meeting between the International Geneva/Springfield Symposium on Advances in Alzheimer Therapy (AAT) and AD/PD,TM the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development, and clinical trials in Alzheimer's, Parkinson's, and other related neurological disorders were at the forefront of the meeting. In this activity, 2 experts summarize the key learnings from this year’s conference focusing on AD.
ATS 2018: An Update on Scientific Advances and Clinical Strategies in Interstitial Lung Disease (ILD)Format: Conference Reporter
The American Thoracic Society (ATS) International Conference was held in San Diego, California, May 18-23, 2018. The ATS international conference is the longest running, large-scale conference in the world offering groundbreaking research in pulmonary, critical care, and sleep medicine. In this activity, 2 experts summarize the key learnings from this year’s conference focusing on strategies in interstitial lung disease (ILD).
This CME-accredited Point-of-Care 201™ program is intended for rheumatologists and other clinicians involved in the management of patients with rheumatoid arthritis (RA). During the video activity, two expert rheumatologists will translate the latest guidelines and clinical trial data into practical recommendations on the use of imaging modalities for the assessment of patients with RA. Topics will include reviews of various imaging techniques, use of ultrasonography to examine synovial inflammation and other changes in RA-affected joints, and application of imaging results to guide shared clinical decision-making with patients.
During this web-based Clinical Issues™ program, a panel of expert faculty will discuss and debate a series of topics related to comprehensively evaluating and longitudinally managing patients with severe asthma, including how the evolving evidence base should shape clinical decision-making and implications of new study data presented at the 2018 American Thoracic Society International Conference.
ATS 2018: An Update on Scientific Advances and Clinical Strategies in Chronic Obstructive Pulmonary Disease (COPD)Format: Conference Reporter
The American Thoracic Society (ATS) International Conference was held in San Diego, California, May 18-23, 2018. The ATS International Conference is the longest-running, large-scale conference in the world offering groundbreaking research in pulmonary, critical care, and sleep medicine. In this activity, 2 experts summarize the key learnings from this year’s conference focusing on strategies in chronic obstructive pulmonary disease (COPD).
ADVANCING THE CARE OF SEVERE ASTHMA: Differential Diagnosis, Multidisciplinary Management, and Patient EngagementFormat: Webcast Series
Welcome to this Severe Asthma CME Snapshot ™ video series. Each 15-minute module offers focused, clinically actionable education for primary care providers and other clinicians who manage patients with severe asthma. For a comprehensive curriculum that provides a practical set of recommendations on improving daily functioning and quality of life among patients with severe asthma, clinician learners can complete all 4 modules for a full hour of AMA PRA Category 1 Credit ™.